Pacira | PCRX - Stock

Aktienkurs
23.79
Täglich Wechseln
-0.03 -0.13%
Monatlich
4.21%
Jährlich
-3.14%
Q2 Prognose
23.14




Stock Veränderung Datum
Assertio Holdings USD 24.76M 8.12M 2025-09
Astellas Pharma JPY 297.26B 9.92B 2025-03
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Cara Therapeutics USD 900K 0 2025-03
Coherus Biosciences USD 3.17M 1.12M 2025-12
Heron Therapeutics USD 54.57M 2.33M 2022-12
J&J USD 14.19B 45M 2025-12
Ligand Pharmaceuticals USD 9.13M 2.77M 2025-12
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Novo Nordisk DKK 45.65B 21.26B 2025-06
Omeros USD 712K 266K 2021-09
Pacira USD 152.86M 4.82M 2025-12
Perrigo USD 1.15B 78M 2025-12
Pfizer USD 11.47B 201M 2025-09
Supernus Pharmaceuticals USD 107.1M 63.08M 2025-09
Teva Pharmaceutical Industries USD 3.18B 144M 2025-12
Xeris Pharmaceuticals USD 68.67M 1.21M 2025-12
Zoetis USD 2.43B 35M 2025-12